A bit more than a month of treatment with a compound that stimulates the growth of gut microbes increases the abundance of selected lactose-fermenting bacteria in people with lactose intolerance, potentially paving the way for the first microbiome-based treatment for the condition, researchers have found.
The placebo-controlled study found that 35 days of treatment with the novel galactooligosaccharide (GOS) led to significantly more beneficial gut microbes in men and women with lactose